These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 15251975)

  • 1. Clinical proteomics and biomarker discovery.
    Johann DJ; McGuigan MD; Patel AR; Tomov S; Ross S; Conrads TP; Veenstra TD; Fishman DA; Whiteley GR; Petricoin EF; Liotta LA
    Ann N Y Acad Sci; 2004 Jun; 1022():295-305. PubMed ID: 15251975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
    Calvo KR; Liotta LA; Petricoin EF
    Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
    Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
    Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of early relapse in ovarian cancer using serum proteomic profiling.
    Oh JH; Gao J; Nandi A; Gurnani P; Knowles L; Schorge J
    Genome Inform; 2005; 16(2):195-204. PubMed ID: 16901102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteome informatics for cancer research: from molecules to clinic.
    Brusic V; Marina O; Wu CJ; Reinherz EL
    Proteomics; 2007 Mar; 7(6):976-91. PubMed ID: 17370257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer.
    Kong F; Nicole White C; Xiao X; Feng Y; Xu C; He D; Zhang Z; Yu Y
    Gynecol Oncol; 2006 Feb; 100(2):247-53. PubMed ID: 16229881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for plasma proteomic profiling of cancers.
    Omenn GS
    Proteomics; 2006 Oct; 6(20):5662-73. PubMed ID: 16991194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Discovery of disease biomarkers by ProteinChip system; clinical proteomics as noninvasive diagnostic tool].
    Tomosugi N
    Rinsho Byori; 2004 Dec; 52(12):973-9. PubMed ID: 15675343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncoproteomics: current trends and future perspectives.
    Cho WC; Cheng CH
    Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometry: uncovering the cancer proteome for diagnostics.
    van der Merwe DE; Oikonomopoulou K; Marshall J; Diamandis EP
    Adv Cancer Res; 2007; 96():23-50. PubMed ID: 17161675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics.
    Lee HJ; Lee EY; Kwon MS; Paik YK
    Curr Opin Chem Biol; 2006 Feb; 10(1):42-9. PubMed ID: 16418010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaching clinical proteomics: current state and future fields of application in cellular proteomics.
    Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tárnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Wagener C; Wagner O; Schmitz G
    Cytometry A; 2009 Oct; 75(10):816-32. PubMed ID: 19739086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of biomarkers from mass spectrometry data using a "common" peak approach.
    Fushiki T; Fujisawa H; Eguchi S
    BMC Bioinformatics; 2006 Jul; 7():358. PubMed ID: 16869977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical proteomics and mass spectrometry profiling for cancer detection.
    Solassol J; Jacot W; Lhermitte L; Boulle N; Maudelonde T; Mangé A
    Expert Rev Proteomics; 2006 Jun; 3(3):311-20. PubMed ID: 16771703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and application of protein biomarkers for ovarian cancer.
    Gagnon A; Ye B
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):9-13. PubMed ID: 18196999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers.
    Gortzak-Uzan L; Ignatchenko A; Evangelou AI; Agochiya M; Brown KA; St Onge P; Kireeva I; Schmitt-Ulms G; Brown TJ; Murphy J; Rosen B; Shaw P; Jurisica I; Kislinger T
    J Proteome Res; 2008 Jan; 7(1):339-51. PubMed ID: 18076136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRISM: a data management system for high-throughput proteomics.
    Kiebel GR; Auberry KJ; Jaitly N; Clark DA; Monroe ME; Peterson ES; Tolić N; Anderson GA; Smith RD
    Proteomics; 2006 Mar; 6(6):1783-90. PubMed ID: 16470653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A data review and re-assessment of ovarian cancer serum proteomic profiling.
    Sorace JM; Zhan M
    BMC Bioinformatics; 2003 Jun; 4():24. PubMed ID: 12795817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspective: a program to improve protein biomarker discovery for cancer.
    Aebersold R; Anderson L; Caprioli R; Druker B; Hartwell L; Smith R
    J Proteome Res; 2005; 4(4):1104-9. PubMed ID: 16083259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical considerations for mass spectrometry profiling in serum biomarker discovery.
    Whiteley GR; Colantonio S; Sacconi A; Saul RG
    Clin Lab Med; 2009 Mar; 29(1):57-69. PubMed ID: 19389551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.